Jocelyne Benatar (Medical Officer Cardiology) and Cam Kyle (Chemical Pathologist) discuss Familial Hyperlipidemia (FH), its diagnosis, management, and implications for primary care. Learn about genetic testing, risk assessment, and new treatments to improve patient outcomes.
Topics
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
-
Play now
Take home messages
Presenter
Dr Jocelyne Benatar is a New Zealand based Medical Officer Cardiology and senior research doctor at Auckland City Hospital, where she works within the Green Lane Cardiovascular Service. She completed her MB ChB at the University of Cape Town and later earned a Doctorate of Medicine from the University of Auckland, combining clinical cardiology with a strong research focus.
Jocelyne is internationally recognised for her research into heart attack recovery, secondary prevention, and cardiovascular medication optimisation, and she has led nationally funded studies, including Heart Foundation–supported clinical trials examining whether long‑term medications are always necessary following myocardial infarction. She regularly presents at international cardiology conferences and publishes in leading medical journals.
Presenter
Dr Cam Kyle graduated from Auckland Medical School in 1980 and received his specialist pathology (FRCPA) qualification in Chemical Pathology in 1993. During his training he also completed a PhD degree at the University of Utah in Physiology (with emphasis in Endocrinology and Genetics).
Kyle has been involved in the provision of community pathology services in Auckland since 1993, first as Director of Biochemistry at Medlab (1993-1999), then as Co-Director and later Director of Biochemistry/Immunology at Diagnostic Medlab from 1999 to 2013. He has also been employed as a part time Chemical Pathologist at LabPlus since 2010. He has been a visiting specialist in the Department of Diabetes and Endocrinology within ADHB since 1992; has been an Honorary Senior Lecturer in Molecular Medicine with the University of Auckland since 1995 and involved with provision of pathology education nationally through BPAC since 2005.


